Research & Innovation | Rare Disease Community
How Do Rare-Disease Families Find Medication Information? RareKids-CAN Wants to Hear From You
Published September 10, 2026
At a Glance
RareKids-CAN is inviting youth with rare diseases and parents or caregivers to take part in research about how families find, understand and use information about medications.
The goal is to identify what is working, where information gaps exist and how medication education can be made clearer and more useful for rare-disease families.
The goal is to identify what is working, where information gaps exist and how medication education can be made clearer and more useful for rare-disease families.
Why Study Medication Information?
Families living with rare diseases are often asked to make complicated decisions about medications, treatments and clinical trials.
Reliable information may come from metabolic clinics, pharmacists, patient organizations, research teams, product information, websites and other families. But the amount, quality and accessibility of that information can vary widely.
RareKids-CAN researchers want to understand how youth and caregivers currently search for pharmacology information, which topics matter most to them and what makes a resource genuinely helpful.
What Is RareKids-CAN?
RareKids-CAN is Canada's Pediatric Rare Disease Clinical Trials and Treatment Network.
The national network brings together patients and families, researchers, clinicians, research institutions and other partners to strengthen pediatric rare-disease research and improve access to innovative therapies in Canada.
Its work includes clinical-trial support, pharmacology, patient and family engagement, registry development, transition to adulthood and other areas that affect the full rare-disease research journey.
The national network brings together patients and families, researchers, clinicians, research institutions and other partners to strengthen pediatric rare-disease research and improve access to innovative therapies in Canada.
Its work includes clinical-trial support, pharmacology, patient and family engagement, registry development, transition to adulthood and other areas that affect the full rare-disease research journey.
About the RKC Pharm Ed Study
The study is exploring the experiences, interests and preferences of rare-disease patients and families when learning about medications.
Researchers are interested in how people search for medication information, which subjects they most want to understand, and the strengths and weaknesses of the resources they currently use.
The findings are intended to help guide the development of more family-friendly and accessible pharmacology education resources.
Researchers are interested in how people search for medication information, which subjects they most want to understand, and the strengths and weaknesses of the resources they currently use.
The findings are intended to help guide the development of more family-friendly and accessible pharmacology education resources.
Who Is the Study Looking For?
As of September 2026, RareKids-CAN says the study is looking for people who have experience searching for information about medications used to treat or manage a rare disease and who are either:
- Youth ages 12 to 18 living with a rare disease, or
- A parent or caregiver of a child with a rare disease.
Participation is virtual. RareKids-CAN currently describes the main activity as a 60- to 90-minute virtual focus group, with an optional brief demographics survey.
Eligibility and participation details can change, so anyone interested should confirm the current requirements directly with the study team.
Eligibility and participation details can change, so anyone interested should confirm the current requirements directly with the study team.
Why Youth Voices Matter
Young people gradually take on more responsibility for understanding their diagnosis, medications and treatment choices as they move toward adulthood.
Information designed only for clinicians or parents may not answer the questions youth themselves have. Including youth directly in research can help ensure future resources are understandable, relevant and useful to the people who will eventually manage more of their own care.
Information designed only for clinicians or parents may not answer the questions youth themselves have. Including youth directly in research can help ensure future resources are understandable, relevant and useful to the people who will eventually manage more of their own care.
What This Means for Amino Allies in Canada
Although this study is not limited to PKU, HCU, MSUD or UCDs, the questions are highly relevant to metabolic families.
Our communities routinely need to understand medications, new therapies, side effects, clinical trials and changing treatment options. Better medication education can support more informed conversations between youth, caregivers and health-care teams.
Participation in research like this is also one way families can help shape resources before they are developed, rather than only being asked for feedback after the fact.
Our communities routinely need to understand medications, new therapies, side effects, clinical trials and changing treatment options. Better medication education can support more informed conversations between youth, caregivers and health-care teams.
Participation in research like this is also one way families can help shape resources before they are developed, rather than only being asked for feedback after the fact.
Interested in Participating?
As of September 10, 2026, RareKids-CAN continues to list this as an active participation opportunity.
Because recruitment details can change, CanPKU+ recommends checking the RareKids-CAN participation page for the latest eligibility, time commitment and study contact information.
Because recruitment details can change, CanPKU+ recommends checking the RareKids-CAN participation page for the latest eligibility, time commitment and study contact information.
Learn More
View Current RareKids-CAN Participation Opportunities Current study details and participation information Learn More About RareKids-CAN
Source:
RareKids-CAN Participation Opportunities and RareKids-CAN network information, accessed September 10, 2026.
About this article: CanPKU+ shares research participation opportunities that may be relevant to our rare metabolic communities. Study inclusion does not indicate endorsement, and current eligibility should always be confirmed with the research team.
Research Articles & Updates
About this article: CanPKU+ shares research participation opportunities that may be relevant to our rare metabolic communities. Study inclusion does not indicate endorsement, and current eligibility should always be confirmed with the research team.
